In-depth trading ideas

Discover detailed market analysis from traders. See how others approach this instrument, compare different strategies, and discover perspectives that can shape your own view.

Jubilant Pharmova Limited Breakout Structure Current Price Action Last Traded Price (LTP): ₹1,011.40 (Up by +3.79% or +₹36.95) Daily Range: Open ₹979.30 | High ₹1,013.90 | Low ₹976.25 Indicators 9 SMA: Currently at ₹976.94 Supertrend (7, 2): Currently at ₹943.08 (indicating a bullish trend) Chart Patterns & Structure Consolidation Channel: The stock spent May, June, and early July consolidative within a defined horizontal rectangular range. Breakout: The current daily candle shows a clear breakout above the Upper Breakout Weekly level (marked around ₹1,019.90). Annotation Note: The chart explicitly notes a "Daily 9 SMA and Super trend break out", indicating strong upward momentum supported by these moving averages. Key Support & Resistance Levels Resistance / Targets Stop Loss: 978 Primary Target: ₹1,118.50 Secondary Target: ₹1,184.80 Full Target: ₹1,248.00 Support / Breakout Levels Upper Breakout Weekly: ₹1,019.90 (Immediate pivot zone being tested) Lower Break Down Weekly: ₹931.05 (Bottom of the consolidation range) Disclaimer: aliceblueonline.com

JUBILANT Pharma - US Facilities One of the few Indian CDMO's which a big enough presence in non-tariff regions. Long above 1120 with Stoploss below 1080. Could make for an interesting short term trade when its competitors might face headwinds from tariffs.

Jubilant Price Action As of July 31, 2025, Jubilant Pharmova Ltd is trading around ₹1,236, showing strong bullish momentum with gains of over 7% in recent sessions. The stock has recovered well from lower levels near ₹1,170 seen earlier, with sustained buyer interest and solid volume support. Technical indicators reveal that the price is above its short-term moving averages, reflecting positive market sentiment. Fundamentally, Jubilant Pharmova maintains a robust position in the pharmaceutical and life sciences sector with steady revenue growth and improving profitability. The company benefits from a diversified business model and ongoing operational efficiencies, which have helped it sustain earnings growth amid industry challenges. Valuation metrics like the price-to-earnings ratio are moderate, reflecting reasonable investor confidence relative to sector peers. The near-term outlook for Jubilant Pharmova appears constructive, with potential for further upside provided it holds above key support levels around ₹1,170–₹1,180. Momentum indicators and volume trends support the continuation of the uptrend, although investors should remain cautious of profit-booking risks after sharp rallies. In summary, Jubilant Pharmova demonstrates solid fundamental strength and positive technical signs, making it an appealing choice for investors seeking exposure to the pharmaceutical sector with a growth orientation.

JUBILANT PHARMOVA- Bullish Flag & Pole Breakout (Daily T/F)Trade Setup 📌 Stock: JUBILANT PHARMOVA ( NSE:JUBLPHARMA ) 📌 Trend: Strong Bullish Momentum 📌 Risk-Reward Ratio: 1:3 (Favorable) 🎯 Entry Zone: ₹1470.00 (Breakout Confirmation) 🛑 Stop Loss: ₹1058.00 (Daily Closing Basis) (-9.5 % Risk) 🎯 Target Levels: ₹1221.15 ₹1269.55 ₹1319.90 ₹1373.55 ₹1433.55 ₹1500.00 (Final Target) Technical Rationale ✅ Bullish Flag & Pole Breakout - Classic bullish pattern confirming uptrend continuation ✅ Strong Momentum - Daily RSI > 60, Weekly RSI >60 Monthly rsi >60 ✅ Volume Confirmation - Breakout volume 520.55K vs previous day's 203.99K ✅ Multi-Timeframe Alignment - Daily and weekly charts showing strength Key Observations • The breakout comes with significantly higher volume, validating strength • Well-defined pattern with clear price & volume breakout • Conservative stop loss at recent swing low Trade Management Strategy • Consider partial profit booking at each target level • Move stop loss to breakeven after Target 1 is achieved • Trail stop loss to protect profits as price progresses Disclaimer ⚠️ This analysis is strictly for educational purposes and should not be construed as financial advice. Trading in equities involves substantial risk of capital loss. Past performance is not indicative of future results. Always conduct your own research, consider your risk appetite, and consult a financial advisor before making any investment decisions. The author assumes no responsibility for any trading outcomes based on this information. What do you think? Are you watching NSE:JUBLPHARMA for this breakout opportunity? Share your views in the comments!

Jubilant Pharmova – Approaching Critical Breakout Zone 🔍 Key Observations The stock has staged a strong rally from the ₹870 support zone and is now testing a critical resistance around ₹1,075–₹1,140. This resistance zone is previously marked as a “Demand turned Supply” area – a major structure where price broke down earlier, and supply emerged. The stock is currently trading just below this zone, and a daily close above it is crucial for a confirmed breakout. ✅ Bullish Signs Multiple CHoCHs (Change of Character) indicate a bullish reversal structure has formed after a prolonged downtrend. Price is now above the 200-day MA and all major moving averages, suggesting the trend bias has turned bullish. Volume has expanded slightly, showing interest building at higher levels. Relative strength vs benchmark index is improving, indicating sector or stock-specific outperformance. ⚠️ What to Watch For A daily or weekly close above ₹1,130 with strong volume will flip the supply zone into demand – confirming the breakout. Failure to break and repeated rejection from this zone could lead to a pullback toward the lower levels. 🧠 Conclusion You're absolutely right — a decisive breakout above the "demand turned supply" zone is crucial. The current price action shows momentum, but confirmation is key. Wait for price to close above ₹1,130 to validate the breakout and avoid a potential bull trap.

WTF Resistence level The Stock is at good level of WTF at Resistence levels if it breaks from here and closes above resistence level on WTF . Good level to Buy

00:55

by adityagupta1

5 Amazing Swing trading ideas discussion I make educational content videos for swing / positional trading

06:24

by Averoy_Apoorv_Analysis

JUBLPHARMA Ready for an Up Move?Hello fellow traders, I hope you are all doing well. Key Observations: 1. Strong Support Zone: JUBLPHARMA has reached a strong zone that previously acted as resistance and could now turn into support. 2. Chart Pattern: A falling wedge pattern is visible, which is typically a bullish reversal signal. We can also see that the breakout has already happened and now the price has come to retest. 3. Bullish Engulfing Candle: On the weekly time frame, we see buying pressure emerging, confirmed by a Bullish Engulfing candle. 4. Entry Point: A good entry could be above ₹1010 for better confirmation of the uptrend. 5. Targets: The potential targets are already marked on the chart as T1, T2, and T3 . As this is my first published idea, I kindly ask you to ignore any mistakes, and I will strive to improve in the future. Disclaimer: This is purely an analysis and not investment advice. Please trade with due diligence and manage your risks carefully. I hope you like my work, Thanks in advance. Best regards - Anantesh

Bullish harmonic in jublpharma in Time frame- DAILY Spotted- Bullish harmonic in jublpharma in Time frame- DAILY Observe whether it respects the harmonic levels. Study-Practice-sharing Educational purpose only. This is not a recommendation - I am not SEBI registered - Do not TRADE/INVEST based on what I publish here. I am not responsible for your loss or gain.

Jubilant Pharmova cmp 1045.00 by Daily Chart view Jubilant Pharmova cmp 1045.00 by Daily Chart view - Support Zone at 912 to 928 Price Band - Resistance Zone at 1043 to 1065 Price Band - Falling Price Channel Breakout and Rising Price Channel is in progress - Daily Support at 970 > 898 > 815 with Resistance at 1115 > 1194 > 1243 > ATH 1309.90

by PIYUSHCHAVDA

JUBLPHARMA Trade set up 1:14+Jubilant Pharmova Limited (JUBLPHARMA) is currently showing a **bullish technical setup** with several key observations: **Current Price and Movement** - The stock is trading at 854.85 INR, up by 9.75 INR (+1.15%) - The stock has experienced a significant upward movement **Technical Highlights** - **Breakout Characteristics**: - Decisively broke above the 1000 level and sustaining the breakout - Breaking out of a consolidation phase lasting over 6 years - Indicates potential long-term uptrend **Trading Insights** - **Price Targets**: - Analyst price target: 1,331.00 INR - Potential targets range from 1,450 to 1,590 - Minimum estimated price: 1,212.00 INR **Technical Indicators** - Bullish engulfing candle on the weekly timeframe - Increased trading volumes highlighting investor interest - RSI currently at 82, indicating the stock is **overbought** in the short term **Risk Management** - Suggested Stop Loss: Weekly close below 1,030 - Risk-Reward ratio estimated at approximately 2.5 **Caution**: Always consult a qualified financial professional before making investment decisions, as trading involves substantial risks

Jubilant Pharma-Consolidation breakout can give good returns Jubilant pharmova has been trading in a big range since last few years. Stock has managed to close above the resistance and has also retested the breakout. Stock has potential to fly from this levels. Keep stock in watchlist. A nifty500 stock and hence can be relatively safer option. Not a recommendation.

by chartistamey

JUBLPHARMA Breakout after 2018 Below are the some points to go through for better analysis: 1. Breakout after 2018 2. Risk Reward is almost 2.5. 3. Did not fall even Nifty fall Disclaimer: Content shared on or through social site channels are for information and education purposes only and should not be treated as investment or trading advice. Please do your own analysis or take independent professional financial advice before making any investments based on your own personal circumstances. Investment in securities are subject to market risks, please carry out your due diligence before investing. And last but not the least, past performance is not indicative of future returns.

Wave Confirmation = Strong Buy Here’s my analysis on Jubilant, RSI and Stochastic indicators are signaling a strong buy, with a clear flag breakout and a healthy 30% retracement. The chart highlights the target areas. Please remember, this is shared solely for educational purposes in technical analysis. Thanks for checking it out, and follow me for more insights! Weekly Timeframe : MACD - RSI - Stoch = Strong buy Daily - RSI & Stoch = Strong Buy Candle - Bullish Candle Volume - Above Average EMA - Positive Crossover Chart Pattern - Flag & Pole BO FIB Retracement - 30% Divergence - N/A This is not a trade signal or call. I’m sharing my technical analysis purely for educational purposes, aiming to improve my own skills and to provide insights into technical analysis for anyone interested. Use this information responsibly and make trading decisions at your own discretion

by Sudhakar_Acharya

JUBLPHARMA Long Term Trade Buy Above 1249 Target -:1259,1268 +++ Can Hold For Long Term Also #Jublpharma

by UnknownUnicorn62517722

convincingly broken through its long-term resistance ✅ The stock has convincingly broken through its long-term resistance level of 1044 which has been in place for over 6 years. This breakout signals a major bullish reversal in the stock's long-term trend. ✅ The breakout is backed by a notable surge in volume, adding credibility to the move and reducing the risk of a false breakout. The increased buying interest at higher levels shows market confidence in further upside. ✅ The RSI is currently at 82 signaling that the stock is heavily overbought in the short term. While this suggests strong momentum, it also increases the likelihood of a near-term retracement or consolidation. ✅ It would be prudent to wait for a retracement to the 1000-1050 range before entering fresh positions. A successful retest of this level would provide a strong entry point for a potential long-term rally. ✅The pharmaceutical sector has been performing well, with growing demand for healthcare services and pharmaceuticals post-pandemic. Other stocks in the sector have experienced significant rallies, including Dr. Reddy's, Sun Pharma, and Divi’s Labs. Given the broader sectoral strength Jubilant Pharmova is expected to follow suit especially after this long-term breakout.

JUBILIANT PHARMOVA BREAKOUT AFTER 6 YEARS The stock has been in consolidation phase since january 2018 and could not breach 888 and 1039 resistance respectively however lately the stock has smashed both of them and rallied to an unstoppable territory The volumes also indicate pretty good buying also DIIs have increased their holdings in the stock The company formed cup and handle in 2019 but failed badly nevertheless the stock rebounded pretty well and gave a pretty goood breakout lately The company has more than 132 patents and is engaged in pharmaceuticals , contract research and development services TARGET - 1800

by keshavmaharaj958

Jubilant Pharmova Ltd - Breakout Setup, Move is ON...#JUBLPHARMA trading above Resistance of 1039 Next Resistance is at 1654 Support is at 780 Here are previous charts: Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.

by MandeepSinghKohli

JUBLPHARMA - 6 Years -Consolidation breakout - Wkly JUBLPHARMA - Price consolidated 6 years and gave breakout with very good volume. Good setup to enter if it retest the breakout around 1000 levels. Name - JUBLPHARMA Pattern - Consolidation Breakout Timeframe - Daily Volume - Very Good volume Cmp - 1191 Target - 1836 SL - 976 Here’s a summary of Jubilant Pharmova Ltd’s Q1 FY25 results: Financial Highlights Net Profit: Jubilant Pharmova reported a net profit of INR 482.10 crore, a substantial increase from INR 6.40 crore in the same quarter last year1. Revenue: The total revenue for the quarter was INR 1,731.70 crore, up by 9.12% YoY1. Operating Profit: Operating profit surged to INR 556.70 crore, a remarkable 596.75% increase YoY1. Operational Highlights Operating Margin: The operating margin improved significantly to 32.15%, up by 538.49% YoY1. Expenses: Total operating expenses decreased by 33.13% QoQ to INR 1,175 crore1. Comparative Performance Quarter-over-Quarter: Compared to the previous quarter, revenue grew by 3.2%, and net profit increased by 5.6%1. Outlook The strong performance in Q1 indicates a positive trend for the rest of the fiscal year, driven by robust revenue growth and improved operational efficiency.

by DailyCharts03

Jubilant Pharmova Ltd - Breakout Setup, Move is ON...#JUBLPHARMA trading above Resistance of 866 Next Resistance is at 1039 Support is at 719 Here are previous charts: Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.

by MandeepSinghKohli

JUBLPHARAMA WEEKLY BREAKOUT Strong breakout on weekly time frame as well day time frame , volume brakout also seen .

by suitableAnalys32992

JUBLPHARMA bullish; above 1066? - Friday, 13 September.JUBLPHARMA: Bullish if ~6 year long consolidation range is broken on good volumes and sustains. The above information does not constitute investment/trading recommendation and it is purely for educational purpose.... INTRADAY Trading Strategy in 3 stages of breakouts: 1) Impulse upmove stage: The strong upmove (nearly upto 1.5% from trigger-price) happens within five minutes. "High Risk Traders" buy on breakouts in hope of continuation of upmove. "High Risk Traders" may have to patiently wait through the Pullback-Consolidation stage to realize profits. High risk:High reward set up as breakouts may fakeout (reversal)also 2) Pullback-Consolidation stage: After the above "Impulse upmove stage"; the price may then pull back and move sideways (between "Open" price and "High" of the above "Impulse upmove stage"). "Safe traders" with minimum risk profile wait for a breakout from the consolidation stage to enter into trade , to book high profits in the final "Breakout continuation" stage 3) Breakout continuation: Stocks often in the third stage breaks up above the "High" of the first "Impulse upmove stage" and continue to go higher again.(another 2-3%) Both Safe Traders/High Risk Traders book profits at this stage SWING Trading Strategy: Position is kept open, only upon stock closing above the entry price on day closing basis and is held on for 5-10 trading sessions for larger gains (5-10%) The above information do not constitute, financial, investment, trading, or other types of advice or recommendation. It is purely for educational purpose....

by JJ_Breakouts

Cup and Handle Formation for a Multi-Year Breakout Key Characteristics of a Cup and Handle Formation for a Multi-Year Breakout: Volume: I ncreased volume during the formation of the cup and handle can indicate growing interest and potential buying pressure. Breakout: A strong breakout above the handle's resistance level, accompanied by increased volume, is a bullish signal. Multi-Year Significance: For a multi-year breakout, the cup and handle formation should span over a significant period, indicating a major reversal in market sentiment. Disclaimer: This analysis is based on historical data and technical indicators. It does not constitute financial advice. Always consult with a financial advisor before making investment decisions.

by supertraders_india